CClinicalTrials.gg
CompletedNCT02288416Updated Sep 10, 2018

Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening

An interventional study of educational intervention and questionnaire administration in Anxiety, No Evidence of Disease and Lung Carcinoma, sponsored by City of Hope Medical Center. Completed at 1 site in United States. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-10.

Sponsored by City of Hope Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
55 Years and older
Sex
All
01

Study summary

This pilot trial studies a video-based intervention in reducing anxiety in patients undergoing lung cancer screening. Giving a video-based intervention to patients prior to lung cancer screening may reduce anxiety and improve the well-being and quality of life.

Read the detailed description

PRIMARY OBJECTIVES:

I. Test the feasibility and acceptability of the video-based intervention.

SECONDARY OBJECTIVES:

I. To describe incidence, degree, and duration of screen-related anxiety among individuals scheduled to undergo low-dose computed tomography (CT) scan (LDCT) for lung cancer screening (LCS).

II. To describe baseline patient characteristics and pre-screening anxiety levels.

III. To describe the preliminary outcomes on screen-related anxiety for patients both not in the intervention group and those in the intervention group.

OUTLINE: Patients are assigned to 1 of 2 groups.

GROUP I: Patients receive standard of care following LCS consisting of routine visits and telephone contact with the LCS program nurse practitioner and coordinator.

GROUP II: Patients undergo a video-based intervention prior to undergoing LCS. Patients watch a 5-minute video that focuses on preparing patients for LCS by providing information on the following: program team and contact information; reason to be screened; screening eligibility; how screening is performed; what to expect on the day of screening; what to expect after screening; what to expect if result is positive; what to expect if result is negative; and risks of screening. Patients also receive an educational handbook. Patients with positive scans (a Lung-Imaging Reporting and Data Systems [RADS] 3 or 4) receive additional brochure and nursing support within 1 week after notification of scan results.

After completion of LCS, patients are followed up at 1 week and then at 3 and 7 months.

02

Conditions studied

  • Anxiety
  • No Evidence of Disease
  • Lung Carcinoma
03

In context

Lung Neoplasms

7,243 studies on the registry are indexed under Lung Neoplasms; 1,557 are open to participants now.

This study's enrollment of 20 is below the median of 60 across 5,295 interventional studies indexed under Lung Neoplasms.

Browse Lung Neoplasms studies →

Lead sponsor

City of Hope Medical Center is the lead sponsor of 670 studies on the registry; 181 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 12 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • This study will be conducted in people scheduled to undergo baseline LDCT as part of the City of Hope (COH) LCS program
  • There are no restrictions related to performance status and life expectancy
  • All subjects must have the ability to understand and the willingness to participate in the informed consent process, although a waiver of written informed consent is obtained for this study

Exclusion criteria

Exclusion Criteria:

  • Patients who do not speak or read, because all intervention materials, including the video and written materials are in English
  • Subjects, who in the opinion of the investigator, may not be able to comply with study procedures
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    Group I (standard of care)

    Patients receive standard of care following LCS consisting of routine visits and telephone contact with the LCS program nurse practitioner and coordinator.

    Other: questionnaire administration · Other: quality-of-life assessment · Other: Best Practice

  • Experimental
    Group II (video-based intervention)

    Patients undergo a video-based intervention prior to undergoing LCS. Patients watch a 5-minute video that focuses on preparing patients for LCS by providing information on the following: program team and contact information; reason to be screened; screening eligibility; how screening is performed; what to expect on the day of screening; what to expect after screening; what to expect if result is positive; what to expect if result is negative; and risks of screening. Patients also receive an educational handbook. Patients with positive scans (a Lung-RADS 3 or 4) receive additional brochure and nursing support within 1 week after notification of scan results.

    Other: educational intervention · Other: questionnaire administration · Other: quality-of-life assessment

Interventions

  • Othereducational intervention

    Undergo video-based intervention

    Also known as: intervention, educational

  • Otherquestionnaire administration

    Ancillary studies

  • Otherquality-of-life assessment

    Ancillary studies

    Also known as: quality of life assessment

  • OtherBest Practice

    Also known as: standard of care, standard therapy

06

What researchers measure

Primary outcomes

  1. Percent of patients who complete the intervention

    Descriptive statistics will be presented on participation in all components of the intervention.

    Time frame: Baseline

  2. Patient satisfaction with the timing, content, and delivery of the video-based intervention assessed by survey

    This self-reported measure will be completed by subjects who received the intervention.

    Time frame: Up to 7 months

Secondary outcomes

  1. Patient screen-related anxiety as assessed by the mean score of the State Trait Anxiety Inventory (STAI)

    The survey is used to diagnose anxiety and to distinguish it from depressive syndromes, with items rated on a 4-point scale (with 1 being "Almost Never" and 4 being "Almost Always").

    Time frame: Baseline to 7 months

  2. Health-related quality of life as assessed by the mean survey score of the Short Form-12 (SF-12) questionnaire

    The SF-12 is designed for assessment of general health status and contains 7 items that measure physical functioning, role functioning, bodily pain, energy/fatigue, social functioning, mental health, emotional functioning, general health perceptions, and changes in health.

    Time frame: Up to 7 months

  3. Consequences of screening, assessed by the mean survey score of the Consequences of Screening in Lung Cancer (COS-LC) questionnaire

    This questionnaire is a non-validated adapted version of a validated two part tool used to assess the psychological impact to breast cancer screening using mammography.

    Time frame: Up to 7 months

07

Study locations

1 site
  • City of Hope Medical Center
    Duarte, California 91010, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02288416
Lead sponsor
City of Hope Medical Center
Collaborators
National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
Nov 11, 2014
Start date
Dec 8, 2014
Primary completion
Sep 6, 2018
Completion
Sep 6, 2018
Last update
Sep 10, 2018

Study contacts

Dan Raz
principal investigator · City of Hope Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion